▶ 調査レポート

心肺負荷検査システムの世界市場分析・規模・シェア・成長・動向・予測:製品種類別、最終用途別

• 英文タイトル:Cardiopulmonary Stress Testing Systems Market (Product Type - Cardiopulmonary Exercise Testing (CPET) Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography (SPECT); End-user - Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Transparency Market Researchが調査・発行した産業分析レポートです。心肺負荷検査システムの世界市場分析・規模・シェア・成長・動向・予測:製品種類別、最終用途別 / Cardiopulmonary Stress Testing Systems Market (Product Type - Cardiopulmonary Exercise Testing (CPET) Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography (SPECT); End-user - Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 / TPM-B04287資料のイメージです。• レポートコード:TPM-B04287
• 出版社/出版日:Transparency Market Research / 2017年11月
• レポート形態:英文、PDF、200ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥620,065 (USD5,795)▷ お問い合わせ
  Multi User¥941,065 (USD8,795)▷ お問い合わせ
  Global Site License¥1,262,065 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、心肺負荷検査システムの世界市場について調べ、心肺負荷検査システムの世界規模、市場動向、市場環境、製品種類別分析、最終用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・心肺負荷検査システムの世界市場動向
・心肺負荷検査システムの世界市場環境
・心肺負荷検査システムの世界市場規模
・心肺負荷検査システムの世界市場規模:製品種類別
・心肺負荷検査システムの世界市場規模:最終用途別
・心肺負荷検査システムの世界市場:地域別市場規模・分析
・心肺負荷検査システムの北米市場規模・予測
・心肺負荷検査システムのアメリカ市場規模・予測
・心肺負荷検査システムの中南米市場規模・予測
・心肺負荷検査システムのヨーロッパ市場規模・予測
・心肺負荷検査システムのアジア市場規模・予測
・心肺負荷検査システムの日本市場規模・予測
・心肺負荷検査システムの中国市場規模・予測
・心肺負荷検査システムのインド市場規模・予測
・心肺負荷検査システムの中東市場規模・予測
・心肺負荷検査システムのアフリカ市場規模・予測
・競争状況・関連企業情報

Global Cardiopulmonary Stress Testing Systems: Overview

Global cardiopulmonary stress testing systems market is mainly driven by the rising demand for high value low volume products, and increasing innovations in the new product launches. The market is witnessing growing trend of introduction of wireless devices, and increasing awareness for early diagnosis of cardiovascular diseases is anticipated to steer the global market growth. Significant technological advancement in cardiopulmonary stress testing systems are likely to drive the market growth, and value added service assistance of these devices serves as major opportunity for the players operating in the cardiopulmonary stress testing systems space.

Global Cardiopulmonary Stress Testing Systems: Scope of Study

The market overview section of the report comprises qualitative analysis of the overall cardiopulmonary stress testing systems market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis for the product type, and end-user, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period which are likely to affect the market dynamics. The applied SWOT analysis has also been provided global cardiopulmonary stress testing systems market. The mortality rate due to cardiovascular diseases has been given for the global cardiopulmonary stress testing systems. The report also covers the regulatory scenario for PMA and CE mark approval of cardiopulmonary stress testing systems.

Global Cardiopulmonary Stress Testing Systems: Market Segmentation

The global cardiopulmonary stress testing systems market is segmented in terms of product type, end-user, and regions. Based on product type, the global cardiopulmonary stress testing systems market is categorized into cardiopulmonary exercise testing systems, pulse oximeters, stress electrocardiograph, stress blood pressure monitors, and single-photon emission computed tomography. The segment cardiopulmonary exercise testing systems is likely to dominate the global cardiopulmonary stress testing systems market during the forecast period. In terms of end-user segment, the global cardiopulmonary stress testing systems market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and specialty clinics/cardiology clinics.

Geographically, the cardiopulmonary stress testing systems market has been categorized into five regions namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2015 to 2025, in terms of product type, technique, application, and distribution channel, along with the CAGR (%) for the forecast period 2017 to 2025.

Global Cardiopulmonary Stress Testing Systems: Competitive Landscape

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global cardiopulmonary stress testing systems market, in terms of percentage share in 2016 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global cardiopulmonary stress testing systems market such as include Koninklijke Philips N.V., Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.), General Electric Company (GE Healthcare), MGC Diagnostics Corporation, OSI Systems, Inc. (Spacelabs Healthcare), Masimo, NIHON KOHDEN CORPORATION, COSMED, Halma plc (SunTech Medical, Inc.), Schiller AG, and Vyaire Medical, Inc., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

The global cardiopulmonary stress testing systems market has been segmented as follows:

Global Cardiopulmonary Stress Testing Systems Market, by Product Type
Cardiopulmonary Exercise Testing (CPET) Systems
Stress ECG
Pulse Oximeters
Stress Blood Pressure Monitors
Single-Photon Emission Computed Tomography (SPECT)
Global Cardiopulmonary Stress Testing Systems Market, by End-user
Hospitals
Specialty Clinics/Cardiology Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Global Cardiopulmonary Stress Testing Systems Market, by Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectivesv
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiopulmonary Stress Testing Systems Market

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.1.1. Rising awareness among end-users about accurate assessment of cardiovascular diseases due to new monitoring technologies is significantly enhancing the diagnosis rate
4.4.1.2. Growing geriatric population propels adoption of preventive disease-monitoring products
4.4.2. Restraints
4.4.2.1. Shutdown of Chalk River resulting in shortage of Tc-99 m and reduction in the number of SPECT procedures
4.4.2.2. Implementation of legal provisions that promote cost containment/cost-cutting strategies
4.4.3. Opportunity
4.5. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, 2015–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Porter’s Five Force Analysis
4.7. Market Outlook
4.8. Regulatory Scenarios
4.9. Cardiovascular Diseases Prevalence, by Region
4.10. Applied SWOT Analysis

5. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By Product Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Product Type, 2015–2025
5.4.1. Cardiopulmonary Exercise Testing (CPET) Systems
5.4.2. Stress ECG
5.4.3. Pulse Oximeters
5.4.4. Stress Blood Pressure Monitors
5.4.5. Single-Photon Emission Computed Tomography (SPECT)
5.5. Product Type Comparison Matrix
5.6. Market Attractiveness By Product Type

6. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By End-user
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast By End-user, 2015–2025
6.4.1. Hospitals
6.4.2. Specialty Clinics/Cardiology Clinics
6.4.3. Ambulatory Surgical Centers
6.4.4. Diagnostic Centers
6.5. Market Attractiveness By End-user

7. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Policies and Regulations
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East and Africa
7.4. Market Attractiveness By Country/Region

8. North America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.1.2. Key Trends
8.2. Market Value Forecast By Product Type, 2015–2025
8.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
8.2.2. Stress ECG
8.2.3. Pulse Oximeters
8.2.4. Stress Blood Pressure Monitors
8.2.5. Single-Photon Emission Computed Tomography (SPECT)
8.3. Market Value Forecast By End-user, 2015–2025
8.3.1. Hospitals
8.3.2. Specialty Clinics/Cardiology Clinics
8.3.3. Ambulatory Surgical Centers
8.3.4. Diagnostic Centers
8.4. Market Value Forecast By Country, 2015–2025
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product Type
8.5.2. By End-user
8.5.3. By Country

9. Europe Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Key Trends
9.2. Market Value Forecast By Product Type, 2015–2025
9.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
9.2.2. Stress ECG
9.2.3. Pulse Oximeters
9.2.4. Stress Blood Pressure Monitors
9.2.5. Single-Photon Emission Computed Tomography (SPECT)
9.3. Market Value Forecast By End-user, 2015–2025
9.3.1. Hospitals
9.3.2. Specialty Clinics/Cardiology Clinics
9.3.3. Ambulatory Surgical Centers
9.3.4. Diagnostic Centers
9.4. Market Value Forecast By Country/Sub-region, 2015–2025
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country/Sub-region

10. Asia Pacific Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Key Trends
10.2. Market Value Forecast By Product Type, 2015–2025
10.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
10.2.2. Stress ECG
10.2.3. Pulse Oximeters
10.2.4. Stress Blood Pressure Monitors
10.2.5. Single-Photon Emission Computed Tomography (SPECT)
10.3. Market Value Forecast By End-user, 2015–2025
10.3.1. Hospitals
10.3.2. Specialty Clinics/Cardiology Clinics
10.3.3. Ambulatory Surgical Centers
10.3.4. Diagnostic Centers
10.4. Market Value Forecast By Country/Sub-region, 2015–2025
10.4.1. India
10.4.2. China
10.4.3. Japan
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region

11. Latin America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Key Trends
11.2. Market Value Forecast By Product Type, 2015–2025
11.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
11.2.2. Stress ECG
11.2.3. Pulse Oximeters
11.2.4. Stress Blood Pressure Monitors
11.2.5. Single-Photon Emission Computed Tomography (SPECT)
11.3. Market Value Forecast By End-user, 2015–2025
11.3.1. Hospitals
11.3.2. Specialty Clinics/Cardiology Clinics
11.3.3. Ambulatory Surgical Centers
11.3.4. Diagnostic Centers
11.4. Market Value Forecast By Country/Sub-region, 2015–2025
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region

12. Middle East and Africa Cardiopulmonary Stress Testing Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Key Trends
12.2. Market Value Forecast By Product Type, 2015–2025
12.2.1. Cardiopulmonary Exercise Testing (CPET) Systems
12.2.2. Stress ECG
12.2.3. Pulse Oximeters
12.2.4. Stress Blood Pressure Monitors
12.2.5. Single-Photon Emission Computed Tomography (SPECT)
12.3. Market Value Forecast By End-user, 2015–2025
12.3.1. Hospitals
12.3.2. Specialty Clinics/Cardiology Clinics
12.3.3. Ambulatory Surgical Centers
12.3.4. Diagnostic Centers
12.4. Market Value Forecast By Country/Sub-region, 2015–2025
12.4.1. South Africa
12.4.2. GCC Countries
12.4.3. Israel
12.4.4. Rest of Middle East and Africa
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region

13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Market Share Analysis By Company (2016)
13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.3.1. Koninklijke Philips N.V.
13.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.1.2 Financial Overview
13.3.1.3 Product Portfolio
13.3.1.4 SWOT Analysis
13.3.1.5 Strategic Overview
13.3.2. Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
13.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.2.2 Financial Overview
13.3.2.3 Product Portfolio
13.3.2.4 SWOT Analysis
13.3.2.5 Strategic Overview
13.3.3. General Electric Company (GE Healthcare)
13.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.3.2 Financial Overview
13.3.3.3 Product Portfolio
13.3.3.4 SWOT Analysis
13.3.3.5 Strategic Overview
13.3.4. MGC Diagnostics Corporation
13.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.4.2 Financial Overview
13.3.4.3 Product Portfolio
13.3.4.4 SWOT Analysis
13.3.4.5 Strategic Overview
13.3.5. OSI Systems, Inc. (Spacelabs Healthcare)
13.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.5.2 Financial Overview
13.3.5.3 Product Portfolio
13.3.5.4 SWOT Analysis
13.3.5.5 Strategic Overview
13.3.6. Masimo
13.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.6.2 Financial Overview
13.3.6.3 Product Portfolio
13.3.6.4 SWOT Analysis
13.3.6.5 Strategic Overview
13.3.7. NIHON KOHDEN CORPORATION
13.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.7.2 Financial Overview
13.3.7.3 Product Portfolio
13.3.7.4 SWOT Analysis
13.3.7.5 Strategic Overview
13.3.8. COSMED
13.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.8.2 Financial Overview
13.3.8.3 Product Portfolio
13.3.8.4 SWOT Analysis
13.3.8.5 Strategic Overview
13.3.9. Halma plc (SunTech Medical, Inc.)
13.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.9.2 Financial Overview
13.3.9.3 Product Portfolio
13.3.9.4 SWOT Analysis
13.3.9.5 Strategic Overview
13.3.10. Schiller AG
13.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.10.2 Financial Overview
13.3.10.3 Product Portfolio
13.3.10.4 SWOT Analysis
13.3.10.5 Strategic Overview
13.3.11. Vyaire Medical, Inc.
13.3.11.1 Company Overview (HQ, Business Segments, Employee Strengths)
13.3.11.2 Financial Overview
13.3.11.3 Product Portfolio
13.3.11.4 SWOT Analysis
13.3.11.5 Strategic Overview

14. Key Take Away

List of Tables

Table 01: Medical Device Classification as per U.S. FDA
Table 02: Code of Federal Regulations, by Type of Device
Table 03: Supplements for Pre-market Approval, by Type of Supplement, 1986–1997
Table 04: Medical Device Classification as per European Commission (EC)
Table 05: Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 06: Global Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Cardiopulmonary Stress Testing Systems Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 10: North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 11: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 12: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 13: Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 14: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 15: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 16: Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 18: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 20: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 21: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 22: Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by End-user, 2015–202